Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntertek Group Regulatory News (ITRK)

Share Price Information for Intertek Group (ITRK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,714.00
Bid: 4,742.00
Ask: 4,744.00
Change: -30.00 (-0.63%)
Spread: 2.00 (0.042%)
Open: 4,780.00
High: 4,790.00
Low: 4,714.00
Prev. Close: 4,744.00
ITRK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

1 Aug 2007 14:01

Intertek Group PLC01 August 2007 Stock Exchange Release 1 August 2007, 14:00pm: London, UK Intertek announces an acquisition and new outsourcing dealsIntertek Group plc (Intertek), the leading international provider of quality and safety services to a wide range of industries, announces the acquisition of Product Quality Partners Inc (QP) and two new outsourcing deals with Imperial Chemical Industries plc ('ICI') and Eastman Kodak Company. QP was purchased from its shareholders Debra and Tom Hodgens for cashconsideration of USD8.25 million (GBP4.1 million). QP provides consultancy,testing and certification services to major wireless and mobile applicationproviders, network carriers, and handset and accessory manufacturers. Thecompany has around 30 employees and has operations in the USA in Texas,Illinois, New Jersey and California. QP is recognised as a leader in North America in wireless device and application testing and supports manufacturers with specialised services to achieve interoperability and carrier network compatibility. Intertek is already a leader in mobile device testing in North America. QP's expertise will enhance its service-offering in the area of application testing for mobile devices. ICI, one of the world's major coatings, adhesives, starch and synthetic polymers businesses, has awarded Intertek a four-year outsourcing contract for analytical laboratory services. As part of the deal, Intertek has acquired the business assets of ICI's Measurement Science Group (MSG) for a total cash consideration of GBP7.8 million. All 42 current MSG staff will transfer to Intertek. MSG's operations will add to Intertek's global network of analytical and measurement services. Located in Teesside, UK, MSG has extensive capabilities and expertise in chemicals, polymers, and pharmaceuticals and can support European and global markets. Kodak's Eastman Gelatine Corporation has agreed to outsource analytical testing laboratory services in Massachusetts, USA to Intertek for three years. Under the agreement, six employees will transfer to Intertek. Wolfhart Hauser, Chief Executive Officer of Intertek, commented:"These three deals demonstrate Intertek's commitment to increasing the breadth and depth of services provided to our customers. The combination of strategic acquisitions and new outsourcing relationships allow us to add new expertise and resources into our global network to support demand from customers". -ends- Contacts Aston Swift / Sarah Ogilvie IntertekTelephone: +44 (0) 20 7396 3400aston.swift@intertek.com / sarah.ogilvie@intertek.com Richard Mountain / Susanne Walker, Financial DynamicsTelephone: +44 (0) 20 7831 3113richard.mountain@fd.com / susanne.walker@fd.com Notes to Editors ABOUT INTERTEK Intertek (LSE: ITRK) is the leading international provider of quality and safety services to a wide range of global and local industries. Partnership with Intertek brings increased value to customers' products and processes, ultimately supporting their success in the global market place. Intertek has the experience, expertise, resources and global reach to support its customers through their network of 980 laboratories and offices, over 19,000 people in 109 countries around the world. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Jun 20241:00 pmRNSDirector/PDMR Shareholding
29th May 20241:00 pmRNSDirector/PDMR Shareholding
28th May 20247:00 amRNSDirectorate Change
24th May 20241:30 pmRNSResult of AGM
24th May 20247:00 amRNSTrading Statement
22nd May 20241:00 pmRNSBlock listing Interim Review
22nd Mar 20249:00 amRNSAnnual Financial Report
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
13th Mar 20241:00 pmRNSDirector/PDMR Shareholding
5th Mar 20247:00 amRNSFinal Results
4th Mar 20247:00 amRNSAcquisition
1st Mar 20241:00 pmRNSDirectorate Change
28th Feb 20241:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSTrading Statement
22nd Nov 20231:00 pmRNSBlock listing Interim Review
14th Sep 20231:00 pmRNSDirector Declaration
24th Aug 20237:00 amRNSAcquisition
28th Jul 20237:00 amRNSHalf-year Report
12th Jul 202310:00 amRNSDirectorate Change
7th Jun 20231:00 pmRNSDirector/PDMR Shareholding
31st May 20231:00 pmRNSDirector/PDMR Shareholding
30th May 20233:00 pmRNSHolding(s) in Company
30th May 20231:00 pmRNSBlock listing Interim Review
24th May 202311:00 amRNSResult of AGM
24th May 20237:00 amRNSTrading Statement
3rd May 20237:00 amRNSCapital Markets Event
27th Apr 20234:00 pmRNSDirector Declaration
26th Apr 20234:30 pmRNSDirector Declaration
20th Apr 20234:00 pmRNSDirector Declaration
3rd Apr 20237:00 amRNSAcquisition
24th Mar 20239:00 amRNSNotice of 2023 AGM
21st Mar 20239:00 amRNSAnnual Financial Report
20th Mar 20237:00 amRNSDirectorate Change
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSFinal Results
23rd Dec 202210:00 amRNSDirectorate Change
13th Dec 202211:00 amRNSDirector Declaration
12th Dec 20221:00 pmRNSDirector Declaration
24th Nov 20227:00 amRNSTrading Statement
21st Nov 20221:00 pmRNSBlock listing Interim Review
2nd Aug 20229:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:01 amRNSAcquisition
29th Jul 20227:00 amRNSHalf-year Report
21st Jun 20221:00 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSDirectorate Change
25th May 202211:00 amRNSResult of AGM
25th May 20227:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.